<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Access Maced J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Open Access Maced J Med Sci</journal-id><journal-title-group><journal-title>Open Access Macedonian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">1857-9655</issn><publisher><publisher-name>Republic of Macedonia</publisher-name><publisher-loc>ID Design 2012/DOOEL Skopje</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5985880</article-id><article-id pub-id-type="publisher-id">OAMJMS-6-839</article-id><article-id pub-id-type="doi">10.3889/oamjms.2018.106</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Is There a Place for Local Natural Treatment of Psoriasis?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>El-Gammal</surname><given-names>Agharid</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nardo</surname><given-names>Veronica Di</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Daaboul</surname><given-names>Farah</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tchernev</surname><given-names>Georgi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wollina</surname><given-names>Uwe</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lotti</surname><given-names>Jacopo</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Lotti</surname><given-names>Torello</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib></contrib-group><aff id="aff1"><label>1</label><italic>Department of Nuclear, Subnuclear and Radiation Physics, University of Rome &#x0201c;G. Marconi&#x0201d;, Rome, Italy</italic></aff><aff id="aff2"><label>2</label><italic>Institute of Dermatological and Regenerative Sciences, Dermatology and Nutrition, Via Alfieri 28, Florence 50121, Italy</italic></aff><aff id="aff3"><label>3</label><italic>Medical Institute of Ministry of Interior (MVR-Sofia), Department of Dermatology, Venereology and Dermatologic Surgery General Skobelev Nr 79, Sofia 1606, Bulgaria</italic></aff><aff id="aff4"><label>4</label><italic>Onkoderma - Policlinic for Dermatology and Dermatologic Surgery, General Skobelev 26, Sofia 1407, Bulgaria</italic></aff><aff id="aff5"><label>5</label><italic>St&#x000e4;dtisches Klinikum Dresden, Department of Dermatology and Allergology, Academic Friedrichstrasse 41, Dresden 01067, Germany</italic></aff><aff id="aff6"><label>6</label><italic>University G. Marconi of Rome, Dept. of Nuclear, Subnuclear and Radiation Physics, Rome, Italy</italic></aff><aff id="aff7"><label>7</label><italic>Universit&#x000e0; Degli Studi &#x0201c;G. Marconi&#x0201d;, Institute of Dermatology, Rome, Italy</italic></aff><author-notes><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Veronica Di Nardo. Department of Nuclear, Subnuclear and Radiation Physics, University of Rome &#x0201c;G. Marconi&#x0201d;, Rome, Italy. E-mail: <email xlink:href="studionutrime@gmail.com">studionutrime@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><day>20</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>18</day><month>5</month><year>2018</year></pub-date><volume>6</volume><issue>5</issue><fpage>839</fpage><lpage>842</lpage><history><date date-type="received"><day>23</day><month>1</month><year>2018</year></date><date date-type="rev-recd"><day>21</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>22</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2018 Agharid El-Gammal, Veronica Di Nardo, Farah Daaboul, Georgi Tchernev, Uwe Wollina, Jacopo Lotti, Torello Lotti.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/CC BY-NC/4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>Apitherapy is the medical use of honey bee products (honey, propolis, royal jelly, bee wax, and bee venom) to relieve human ailments, propolis in particularly, rich in essential oils such as flavonoid. Propolis is derived from tree buds and plants. It is considered as one of the most well-documented products from the honeybee and has always played an important role in traditional folk medicine. Another renowned plant is Aloe vera appertaining to the Liliaceae family. Its mucilaginous gel has been extensively used in many cultures for its apparent effectiveness in treating wounds, burns, itchiness and hair loss.</p></sec><sec id="st2"><title>AIM:</title><p>The aim was to assess the efficacy of a mixture in an ointment form of propolis (50%) and aloe vera (3%), in the treatment of mild to moderate psoriasis.</p></sec><sec id="st3"><title>METHODS:</title><p>In this double-blind control study, 2248 patients with both mild to moderate cases of psoriasis were evaluated from 2012 to 2015.</p></sec><sec id="st4"><title>RESULTS:</title><p>In Group 1 the overall response at the end of 12 weeks was as follows: Cleared in 64.4% (excellent response), good response in 22.2%, and weak response in 5.6% and no response in 7.7%. In Group 2 (placebo group) no significant improvement was observed after 12 weeks of treatment. Also, histology also demonstrated a marked reduction in hyperkeratosis and acanthosis.</p></sec><sec id="st5"><title>CONCLUSION:</title><p>In comparison with Group 2 (placebo group) patients in Group 1, treated with a mixture of propolis (50%) and aloe vera (3%), in the form of an ointment have shown noteworthy improvement thus substantiating the therapeutic value of propolis and aloe vera in the treatment of mild to moderate psoriasis.</p></sec></abstract><kwd-group><kwd>Apitherapy</kwd><kwd>Psoriasis</kwd><kwd>Skin disease</kwd><kwd>Natural therapy</kwd><kwd>Propolis</kwd><kwd>Aloe vera</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Psoriasis is an inflammatory and proliferative skin disease with heterogeneous genetic background and is characterised by chronic, sharply demarcated, dull-red scaly plaques on the skin and particularly on the extensor prominences and in the scalp area [<xref rid="ref1" ref-type="bibr">1</xref>]. It is one of the most common chronic skin diseases in need of long-term therapy. Although the multi-factorial aetiology of this disease, a strong association between body mass index and psoriasis severity was shown [<xref rid="ref7" ref-type="bibr">7</xref>]. Until now there has not been an ideal treatment for this perplexing ailment.</p><p>However, a variety of therapeutic approaches have shown limited efficacy with frequent side effects. <italic>In vivo</italic> and <italic>in vitro</italic> data prove the effectiveness of cytokines taken in low-doses [<xref rid="ref1" ref-type="bibr">1</xref>] and antioxidants [<xref rid="ref2" ref-type="bibr">2</xref>] Complementary therapy based on psychotherapeutic approaches has also shown to be effective [<xref rid="ref3" ref-type="bibr">3</xref>].</p><p>The use of apitherapy (using hive products for medical and pharmacological purposes) remains a controversial matter in the treatment of dermatological diseases especially psoriasis [<xref rid="ref5" ref-type="bibr">5</xref>].</p><p>Aloe vera is a plant that has been used in folk medicine; its mucilaginous gel is used for treating itching, hair loss and many other problems. It is also found in modern-day commercial beauty products.</p><p>Aloe vera has also proven effective on the cutaneous burn and wound healing [<xref rid="ref6" ref-type="bibr">6</xref>]. There have been many studies that demonstrated considerable analgesic, antipruritic, wound healing and anti-inflammatory properties [<xref rid="ref4" ref-type="bibr">4</xref>]. These qualities justify investigating Aloe vera in the treatment of psoriasis.</p><p>This study aims to evaluate the efficacy of a combined natural topical treatment for psoriasis. The drug is mainly composed of propolis (one of the most important hive products) and Aloe vera. The ointment is used for topical treatment of mild to moderate psoriasis in all regions of the body except face and genitalia.</p></sec><sec sec-type="material|methods" id="sec1-2"><title>Material and Methods</title><p>In a double-blind placebo-controlled study, 2248 patients of the Center of Dermatology in Heliopolis (Cairo, Egypt), with mild to moderate psoriasis have been included. Patients from 2012 to 2015 were divided into two groups. Group I was treated with an ointment containing a combination of propolis 50% and Aloe vera 3%. Group was II treated with a placebo (ointment without propolis and Aloe vera). Topical treatment was performed for 12 weeks while sparing face and genital.</p><p>Definition of clinical outcome:</p><p>
<list list-type="bullet"><list-item><p>Excellent response: when all psoriatic lesions disappeared, and skin becomes nearly normal (no erythema, no infiltration or desquamation of skin).</p></list-item><list-item><p>Good response: when some of the lesions disappeared.</p></list-item><list-item><p>Weak response: when no marked improvement in erythema, infiltration or desquamation of skin was noted.</p></list-item><list-item><p>No response: when no response occurred at all.</p></list-item></list>
</p><p>The outcome was also evaluated by psoriasis area and severity-score (PASI score) and skin biopsies.</p></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>In Group 1 the overall response at the end of 12 weeks was as follows: Cleared in 64.4% (excellent response), good response in 22.2%, and weak response in 5.6% and no response in 7.7% (Figures <xref ref-type="fig" rid="F1 F2 F3 F4 F5">1</xref>-<xref ref-type="fig" rid="F6">6</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Clinical results of treatment</p></caption><graphic xlink:href="OAMJMS-6-839-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Results of treatment. Percentage of PASI-reduction</p></caption><graphic xlink:href="OAMJMS-6-839-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Histology pre and post-treatment (Biopsy Rt.Sole; HE stain). Within the typical plaque, psoriatic epidermis shows marked epidermal acanthosis, hyperkeratosis, and elongation; the presence of Munro&#x02019;s microabscesses (to the left). Parakeratosis changed to orthokeratosis, acanthosis decreased, the rate ridges became shorter than before TTT; absence of Munro&#x02019;s microabscesses (to the right)</p></caption><graphic xlink:href="OAMJMS-6-839-g003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Pre (left) and post (right) 3 months of treatment</p></caption><graphic xlink:href="OAMJMS-6-839-g004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Pre (left) and post (right) 3 months of treatment</p></caption><graphic xlink:href="OAMJMS-6-839-g005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Pre (left) and post (right) 3 months of treatment</p></caption><graphic xlink:href="OAMJMS-6-839-g006"/></fig><p>The formulation resulted in significant reduction of erythema and scaling. In Group 2 (placebo group) no significant improvement was observed after 12 weeks of treatment. Also, histology also demonstrated a marked reduction in hyperkeratosis and acanthosis.</p><p>The ointment worked for different types of lesions (<xref ref-type="table" rid="T1">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Results of treatment I relation to the type of psoriasis lesions</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" colspan="2" rowspan="3">Type</th><th align="center" colspan="2" rowspan="1">Result</th><th align="center" rowspan="3" colspan="1">Total</th></tr><tr><th align="center" colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Effective</th><th align="center" rowspan="1" colspan="1">Non-Effective</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">Guttate</td><td align="center" rowspan="1" colspan="1">Excellent</td><td align="center" rowspan="1" colspan="1">183</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">183</td></tr><tr><td align="center" rowspan="1" colspan="1">Good</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="center" rowspan="1" colspan="1">Weak</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="center" rowspan="1" colspan="1">No Response</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td></tr><tr><td align="left" colspan="2" rowspan="1">Total</td><td align="center" rowspan="1" colspan="1">207</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">225</td></tr><tr><td align="left" rowspan="4" colspan="1">Palmo</td><td align="center" rowspan="1" colspan="1">Excellent</td><td align="center" rowspan="1" colspan="1">246</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">246</td></tr><tr><td align="center" rowspan="1" colspan="1">Good</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">95</td></tr><tr><td align="center" rowspan="1" colspan="1">Weak</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="center" rowspan="1" colspan="1">No Response</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">38</td></tr><tr><td align="left" colspan="2" rowspan="1">Total</td><td align="center" rowspan="1" colspan="1">341</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">391</td></tr><tr><td align="left" rowspan="4" colspan="1">Plaque</td><td align="center" rowspan="1" colspan="1">Excellent</td><td align="center" rowspan="1" colspan="1">1021</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1021</td></tr><tr><td align="center" rowspan="1" colspan="1">Good</td><td align="center" rowspan="1" colspan="1">380</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">380</td></tr><tr><td align="center" rowspan="1" colspan="1">Weak</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">107</td><td align="center" rowspan="1" colspan="1">107</td></tr><tr><td align="center" rowspan="1" colspan="1">No Response</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">124</td><td align="center" rowspan="1" colspan="1">124</td></tr><tr><td align="left" colspan="2" rowspan="1">Total</td><td align="center" rowspan="1" colspan="1">1401</td><td align="center" rowspan="1" colspan="1">231</td><td align="center" rowspan="1" colspan="1">1632</td></tr></tbody></table></table-wrap><p>We used Psoriasis Area and Severity Index (PASI score) as a method of clinical assessment of patients.</p><p>This is purely clinical rating system which assesses the area of the body affected by the intensity of the main symptoms.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>reduction of PASI score</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">%- Reduction of PASI score</th><th align="center" rowspan="1" colspan="1">Cases</th><th align="center" rowspan="1" colspan="1">Percent</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Effective</td><td align="center" rowspan="1" colspan="1">1947</td><td align="center" rowspan="1" colspan="1">86.70%</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-effective</td><td align="center" rowspan="1" colspan="1">301</td><td align="center" rowspan="1" colspan="1">13.30%</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">2248</td><td align="center" rowspan="1" colspan="1">100%</td></tr></tbody></table></table-wrap><p>A punch biopsy was taken before application of the treatment and stained to be examined histologically (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>Psoriasis is a common systemic inflammatory disorder. In this double-blind placebo-controlled study 2248 patients with mild to moderate psoriasis were enrolled. Group 1 received topical treatment with an ointment containing a combination of propolis and aloe vera. Group 2 received placebo (ointment without aforementioned active compounds. We excluded only facial and genital skin. Tolerability of the treatment was very good.</p><p>Major natural constituents have been used in this trial. The first one is propolis, a non-toxic substance which is composed of resins, waxes and fatty acids, minerals, vitamins, and flavonoids. Flavonoids, caffeic acid-phenethyl ester (CAPE), and hydroxycinnamic acid are responsible for most biological effects including with anti-inflammatory activity. CAPE has both anti-inflammatory and anti-oxidative properties. Since CAPE is lipophilic, it is capable of inhibiting the intracellular LOX and COX enzymes, and thereby indirectly the arachidonic pathway. This action prevents the release of prostaglandins and leukotrienes, and it decreases neutrophil infiltration into the skin [<xref rid="ref4" ref-type="bibr">4</xref>] [<xref rid="ref9" ref-type="bibr">9</xref>].</p><p>No severe side effects were noted. Minimal discomfort due to the texture of the ointment and temporal itching sensation had been observed.</p><p>The other natural ingredients were Aloe vera. Aloe vera has moisturising qualities, which are helpful in restoring disturbed skin barrier function. Aloesin from Aloe vera positively regulated the release of cytokines and growth factors (IL-1&#x003b2;, IL-6, TGF-&#x003b2;1 and TNF-&#x003b1;) from macrophages and enhanced angiogenesis in endothelial cells (HUVECs). Aloesin accelerates wound closure in mice by activating Smad and MAPK signalling proteins that are of utmost importance in cell migration, angiogenesis and tissue development [<xref rid="ref10" ref-type="bibr">10</xref>].</p><p>Topical Aloe vera was more effective in PASI reduction in moderate plaque psoriasis in a randomised, comparative, double-blind 8-weeks trial than 0.1% triamcinolone acetonide [11]. These results are supported by the present study.</p><p>In comparison with Group 2 (placebo group) patients in Group 1, treated with a mixture of propolis (50%) and aloe vera (3%), in the form of an ointment have shown noteworthy improvement thus substantiating the therapeutic value of propolis and aloe vera in the treatment of mild to moderate psoriasis.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Funding:</bold> This research did not receive any financial support</p></fn><fn fn-type="other"><p><bold>Competing Interests:</bold> The authors have declared that no competing interests exist</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barygina</surname><given-names>V</given-names></name><name><surname>Becatti</surname><given-names>M</given-names></name><name><surname>Lotti</surname><given-names>T</given-names></name><name><surname>Taddei</surname><given-names>N</given-names></name><name><surname>Fiorillo</surname><given-names>C</given-names></name></person-group><article-title>Low dose cytokines reduce oxidative stress in primary lesional fibroblasts obtained from psoriatic patients</article-title><source>Dermatol Sci</source><year>2016</year><volume>83</volume><issue>3</issue><fpage>242</fpage><lpage>4</lpage><comment>https://doi.org/10.1016/j.jdermsci.2016.06.002 PMid:27317477</comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barygina</surname><given-names>V</given-names></name><name><surname>Becatti</surname><given-names>M</given-names></name><name><surname>Soldi</surname><given-names>G</given-names></name><name><surname>Prignano</surname><given-names>F</given-names></name><name><surname>Lotti</surname><given-names>T</given-names></name><name><surname>Nassi</surname><given-names>P</given-names></name><name><surname>Wright</surname><given-names>D</given-names></name><name><surname>Taddei</surname><given-names>N</given-names></name><name><surname>Fiorillo</surname><given-names>C</given-names></name></person-group><article-title>Altered redox status in the blood of psoriatic patients:involvement of NADPH oxidase and role of anti-TNF-&#x003b1;therapy</article-title><source>Redox Rep</source><year>2013</year><volume>18</volume><issue>3</issue><fpage>100</fpage><lpage>6</lpage><comment>https://doi.org/10.1179/1351000213Y.0000000045 PMid:23601139</comment><pub-id pub-id-type="pmid">23601139</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capella</surname><given-names>GL</given-names></name><name><surname>Finzi</surname><given-names>AF</given-names></name></person-group><article-title>Complementary therapy for psoriasis</article-title><source>Dermatol Ther</source><year>2003</year><volume>16</volume><issue>2</issue><fpage>164</fpage><lpage>74</lpage><comment>https://doi.org/10.1046/j.1529-8019.2003.01625.x</comment><pub-id pub-id-type="pmid">12919118</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Or&#x00161;oli&#x00107;</surname><given-names>N</given-names></name><name><surname>Skuri&#x00107;</surname><given-names>J</given-names></name><name><surname>Diki&#x00107;</surname><given-names>D</given-names></name><name><surname>Stani&#x00107;</surname><given-names>G</given-names></name></person-group><article-title>Inhibitory effect of a propolis on di-n-propyl disulfide or n-hexyl salycilate-induced skin irritation, oxidative stress and inflammatory responses in mice</article-title><source>Fitoterapia</source><year>2014</year><volume>93</volume><fpage>18</fpage><lpage>30</lpage><comment>https://doi.org/10.1016/j.fitote.2013.12.007 PMid:24370661</comment><pub-id pub-id-type="pmid">24370661</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>SA</given-names></name><name><surname>Madani</surname><given-names>SA</given-names></name><name><surname>Abediankenari</surname><given-names>S</given-names></name></person-group><article-title>The review on properties of Aloe vera in healing of cutaneous wounds</article-title><source>Bio Med Res Intern</source><year>2015</year><volume>2015</volume><fpage>714216</fpage><comment>https://doi.org/10.1155/2015/714216</comment></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hercogov&#x000e1;J</surname><given-names>Ricceri F</given-names></name><name><surname>Tripo</surname><given-names>L</given-names></name><name><surname>Lotti</surname><given-names>T</given-names></name><name><surname>Prignano</surname><given-names>F</given-names></name></person-group><article-title>Psoriasis and body mass index</article-title><source>Dermatol Ther</source><year>2010</year><volume>23</volume><issue>2</issue><fpage>152</fpage><lpage>4</lpage><comment>https://doi.org/10.1111/j.1529-8019.2010.01309.x PMid:20415822</comment><pub-id pub-id-type="pmid">20415822</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lotti</surname><given-names>T</given-names></name><name><surname>Hercogova</surname><given-names>J</given-names></name><name><surname>Prignano</surname><given-names>F</given-names></name></person-group><article-title>The concept of psoriatic disease:can cutaneous psoriasis any longer be separated by the systemic comorbidities?</article-title><source>Dermatol Ther</source><year>2010</year><volume>23</volume><issue>2</issue><fpage>119</fpage><lpage>22</lpage><comment>https://doi.org/10.1111/j.1529-8019.2010.01305.x PMid:20415818</comment><pub-id pub-id-type="pmid">20415818</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasupuleti</surname><given-names>VR</given-names></name><name><surname>Sammugam</surname><given-names>L</given-names></name><name><surname>Ramesh</surname><given-names>N</given-names></name><name><surname>Gan</surname><given-names>SH</given-names></name></person-group><article-title>Honey, Propolis, and Royal Jelly:A Comprehensive Review of Their Biological Actions and Health Benefits</article-title><source>Oxid Med Cell Longev</source><year>2017</year><volume>2017</volume><fpage>1259510</fpage><comment>https://doi.org/10.1155/2017/1259510 PMid:28814983 PMCid:PMC5549483</comment><pub-id pub-id-type="pmid">28814983</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahedi</surname><given-names>HM</given-names></name><name><surname>Jeong</surname><given-names>M</given-names></name><name><surname>Chae</surname><given-names>JK</given-names></name><name><surname>Do</surname><given-names>SG</given-names></name><name><surname>Yoon</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name></person-group><article-title>Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo</article-title><source>Phytomedicine</source><year>2017</year><volume>28</volume><fpage>19</fpage><lpage>26</lpage><comment>https://doi.org/10.1016/j.phymed.2017.02.005 PMid:28478809</comment><pub-id pub-id-type="pmid">28478809</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choonhakarn</surname><given-names>C</given-names></name><name><surname>Busaracome</surname><given-names>P</given-names></name><name><surname>Sripanidkulchai</surname><given-names>B</given-names></name><name><surname>Sarakarn</surname><given-names>P</given-names></name></person-group><article-title>A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis</article-title><source>J Eur Acad Dermatol Venereol</source><year>2010</year><month>2</month><volume>24</volume><issue>2</issue><fpage>168</fpage><lpage>72</lpage><comment>https://doi.org/10.1111/j.1468-3083.2009.03377.x PMid:19686327</comment><pub-id pub-id-type="pmid">19686327</pub-id></element-citation></ref></ref-list></back></article>